The numbers tell a story of a company inching back from the edge. SAP’s shares closed Friday at €159.40, up 1.65 percent on the day and 13.45 percent higher over the past 30 trading sessions. That recovery, however, still leaves the stock roughly 38 percent below the all-time high of €258.60 touched in late July 2025 — a reminder that the wounds from a brutal 12-month stretch, which saw the shares shed 36.66 percent, have only partially healed.
What has changed in recent weeks is the accumulation of supporting signals. Company insiders have been buying, a major shareholder has significantly boosted his voting stake, a €2.6 billion buyback tranche is underway, and German antitrust authorities have quietly closed a preliminary inquiry into the software giant’s data-access practices. Whether these elements are enough to carry the stock through its next major catalyst — third-quarter earnings on October 21 — is the question now dividing the analyst community.
A Regulatory Cloud Lifts
The Bundeskartellamt has ended its preliminary investigation into SAP without opening formal proceedings. The competition authority had been examining allegations, prompted by a complaint from rival Celonis, that SAP was abusing its market power in data access. The closure removes a regulatory overhang that had been hovering over the stock, though it arrives at a moment when investors are far more focused on the company’s financial trajectory than its legal entanglements.
The Margin Squeeze at the Heart of the Debate
The second-quarter results, published July 23, provided the foundation for the recent rally. Cloud revenue rose 24 percent on a currency-adjusted basis to €6.28 billion, while the current cloud backlog — contracted future revenue — grew 26 percent to €22.9 billion. IFRS earnings per share climbed to €1.89 from €1.46 a year earlier.
Yet the headline growth figures obscure a more uncomfortable reality. The company trimmed its 2026 non-IFRS operating profit guidance to a range of €11.8 billion to €12.2 billion, down from a previous target of up to €12.3 billion. The culprit: dilution from two recently completed acquisitions — US data platform Dremio and AI startup Prior Labs, both finalized on July 17. Operating profit rose 9 percent in the quarter on a currency-adjusted basis, solid but noticeably slower than the cloud revenue engine.
The central tension for investors is whether the integration of these platforms will accelerate quickly enough to make the margin drag a temporary phenomenon, or whether the simultaneous absorption of multiple acquisitions will erode profitability longer than the market currently prices in.
Insider Confidence and a Steady Buyback
Against that uncertainty, management has been putting its money where its mouth is. Between July 17 and 24, executives reported twelve insider purchases totaling roughly €3.22 million, including buying by CFO Dominik Asam. A separate mandatory disclosure from July 31 revealed that Harald Tschira had increased his voting rights through voting agreements with Udo Tschira from 0.57 percent to 4.22 percent.
Should investors sell immediately? Or is it worth buying SAP?
The company itself remains an active buyer of its own stock. The second tranche of the 2026 buyback program, launched July 27, authorizes the purchase of up to €2.6 billion worth of shares — approximately 18.5 million shares — running through January 2027. The full program, extending to end-2027, can reach €10 billion. In a period of declining price targets, such signals function as a statement of confidence in the company’s own valuation.
Analysts Split on Fair Value
The post-earnings reaction from the Street has been notably fragmented. Goldman Sachs reaffirmed its “Conviction Buy” stance with a €215 price target on July 27. Jefferies, following investor meetings with CEO Christian Klein on AI strategy, maintained its “Buy” rating with a €210 target on July 28. Deutsche Bank and Berenberg also held firm with recommendations in the €200–€210 range.
Others are more cautious. JPMorgan’s Toby Ogg kept a “Neutral” rating with a €175 target, praising the strong cloud backlog but warning about potential additional spending if anticipated AI revenue fails to materialize. UBS went further, cutting its target to €164 — barely above the current share price. Barclays trimmed to €220. The wide dispersion reflects genuine disagreement over how to weight the competing forces of cloud growth, margin pressure, and acquisition integration costs.
A Chart That Demands Respect
The technical picture adds another layer of complexity. Friday’s close of €159.40 sits 8.74 percent below the 200-day moving average of €174.67 — a persistent reminder that the long-term trend remains downward despite the recent bounce. The stock has recovered meaningfully from its 52-week low of €127.52 hit on July 23, but the annualized volatility of 49.19 percent suggests sharp reversals remain possible at any time.
For bulls, the combination of insider buying, the Tschira stake increase, the active buyback, and the regulatory reprieve points toward a floor being established. The partnership with SIGNAL IDUNA on AI, announced recently, also suggests continued traction in the enterprise customer base. The European Commission’s decision in early July to close its competition case regarding on-premise maintenance and support, after accepting binding commitments from SAP, removed another layer of regulatory uncertainty.
For bears, the math is more sobering. The stock is still down 23.91 percent year-to-date. The gap to the 200-day average indicates the structural downtrend has not yet been broken. If the margin pressure from Dremio and Prior Labs proves deeper or longer-lasting than communicated, the recent rally could quickly lose its foundation.
The October Test
The next concrete checkpoint arrives October 21, when SAP reports third-quarter numbers. By then, the market will have had nearly three months to assess whether the integration of the new platforms is proceeding smoothly and whether the cloud growth engine can continue at its current pace. The question of whether the recovery can extend toward the €200–€210 zone favored by the more optimistic analysts — or whether the trimmed guidance and acquisition costs will weigh more heavily — will likely be answered in the weeks ahead. For now, the stock sits in a zone where conviction and caution are trading at nearly equal prices.
Ad
SAP Stock: Buy or Sell?! New SAP Analysis from August 2 delivers the answer:
The latest SAP figures speak for themselves: Urgent action needed for SAP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 2.
SAP: Buy or sell? Read more here...
